SCHEMBL29566619

SCHEMBL29566619

Cc1ccccc1Oc1cc(-c2ccccc2C)nc(NS(=O)(=O)c2cnn(C)c2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 5/20 0.43
▸ HTR7 P34969 5/20 0.43
▸ BRD4 O60885 3/20 0.41
▸ TSHR P16473 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ DRD2 P14416 2/20 0.37
▸ HTR6 P50406 1/20 0.37
▸ KMT2A Q03164 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ PIK3CD O00329 1/20 0.36
▸ PIK3CB P42338 1/20 0.36
▸ MTOR P42345 1/20 0.36
▸ PIK3CG P48736 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ SCN9A Q15858 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ SLC22A12 Q96S37 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309726 1.00 HTR1A (0.43) HTR1AHTR7BRD4TSHRSMN1; SMN2
SCHEMBL24309574 0.90 BRD4 (0.41) HTR1AHTR7BRD4TSHRSMN1; SMN2
SCHEMBL29567022 0.90 BRD4 (0.41) HTR1AHTR7BRD4TSHRSMN1; SMN2
SCHEMBL29567731 0.88 BRD4 (0.38) BRD4TSHRSMN1; SMN2KMT2ARXFP1
SCHEMBL24310817 0.88 BRD4 (0.38) BRD4TSHRSMN1; SMN2KMT2ARXFP1
SCHEMBL24309255 0.85 DRD2 (0.36) HTR1AHTR7BRD4DRD2HTR6
SCHEMBL29566539 0.85 DRD2 (0.36) HTR1AHTR7BRD4DRD2HTR6
SCHEMBL24309983 0.84 HTR1A (0.39) HTR1AHTR7BRD4TSHRSMN1; SMN2
SCHEMBL26807637 0.84 HTR1A (0.40) HTR1AHTR7BRD4TSHRSMN1; SMN2
SCHEMBL24309256 0.84 HTR1A (0.39) HTR1AHTR7TSHRKMT2ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback